Home › Companies › Corcept Therapeutics Incorporated › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Corcept Therapeutics Incorporated’s Form 8-K, filed May 28, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 21, 2026: 11 items on Corcept Therapeutics Incorporated’s Form 8-K, filed May 28, 2026: 8 elected · 3 approved.
Significant dissent: 1 director (33.9% against); 1 equity or compensation plan (31.0% against).
Notable dissent: 3 directors (16.0%, 12.5%, 12.1% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Tang Capital (13F, 1.4%, as of September 30, 2026)
Explore Corcept Therapeutics Incorporated in the interactive database Compare manager voting policies
These tallies are Corcept Therapeutics Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 28, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Gregg Alton | 67,977,943 | -- | -- | 9,316,514 | 15,975,718 | 88% | Elected | — |
| Elect Director: G. Leonard Baker, Jr. | 64,912,506 | -- | -- | 12,381,951 | 15,975,718 | 84% | Elected | — |
| Elect Director: Joseph K. Belanoff, M.D. | 76,965,512 | -- | -- | 328,945 | 15,975,718 | 99.6% | Elected | — |
| Elect Director: David L. Mahoney | 51,078,278 | -- | -- | 26,216,179 | 15,975,718 | 66% | Elected | — |
| Elect Director: Joshua M. Murray | 76,753,606 | -- | -- | 540,851 | 15,975,718 | 99.3% | Elected | — |
| Elect Director: Kimberly Park | 70,288,833 | -- | -- | 7,005,624 | 15,975,718 | 91% | Elected | — |
| Elect Director: Daniel N. Swisher, Jr. | 67,594,098 | -- | -- | 9,700,359 | 15,975,718 | 87% | Elected | — |
| Elect Director: James N. Wilson | 72,730,017 | -- | -- | 4,564,440 | 15,975,718 | 94% | Elected | — |
| 2. Appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 92,656,473 | 569,010 | 44,692 | -- | -- | 99.4% | Approved | — |
| 3. Compensation of named executive officers | 72,511,429 | 4,560,385 | 222,643 | -- | 15,975,718 | 94% | Approved | — |
| 4. Amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan | 53,163,364 | 23,867,363 | 263,730 | -- | 15,975,718 | 69% | Approved | — |
Source: Corcept Therapeutics Incorporated, Form 8-K, filed with the SEC on May 28, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
357 asset managers disclosed a vote on at least one Corcept Therapeutics Incorporated item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Prior year: 99.8% for (June 10, 2025 meeting) ▼ 0.2 pts
Description as filed by funds: Election of Directors: Joseph K. Belanoff, M.D.
Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Joseph K. Belanoff, M.D.”): 76,965,512 for, 328,945 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 30,619,026 for, 20,494 withheld, 2 abstained, 66,551 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,198,747 | 0 | 2 | 0 | For |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 5,218,560 | 0 | 0 | 0 | For |
| First Trust | 2,173,819 | 0 | 0 | 0 | For |
| State Street | 1,564,463 | 0 | 0 | 130 | For |
| Charles Schwab | 1,021,083 | 0 | 0 | 0 | For |
| Dimensional | 353,405 | 0 | 0 | 0 | For |
| Jackson National | 234,374 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 181,631 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 177,736 | 0 | 0 | 0 | For |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 127,995 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 121,285 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 82,385 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 75,759 | 0 | 0 | 0 | For |
| AQR | 74,174 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 71,812 | 0 | 0 | 0 | For |
| Putnam | 71,394 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 63,836 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 63,129 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Prior year: 99.0% for (June 10, 2025 meeting) ▼ 11.1 pts
Description as filed by funds: Election of Directors: Gregg Alton
Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Gregg Alton”): 67,977,943 for, 9,316,514 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 27,085,523 for, 3,553,933 withheld, 66 abstained, 66,551 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,175,350 | 0 | 66 | 23,333 | For |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 5,208,686 | 0 | 0 | 9,874 | For |
| First Trust | 0 | 0 | 0 | 2,173,819 | Withhold |
| State Street | 1,548,980 | 0 | 0 | 15,613 | For |
| Charles Schwab | 1,021,083 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 353,405 | Withhold |
| Jackson National | 198,027 | 0 | 0 | 36,347 | Mixed |
| Columbia Threadneedle | 181,631 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 177,736 | Withhold |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 53,708 | 0 | 0 | 74,287 | Mixed |
| Janus Detroit Street Trust | 0 | 0 | 0 | 121,285 | Withhold |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 82,385 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 75,759 | Withhold |
| AQR | 0 | 0 | 0 | 74,174 | Withhold |
| Brown Capital Management Mutual Funds | 71,812 | 0 | 0 | 0 | For |
| Putnam | 71,394 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 63,836 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 63,129 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Prior year: 96.8% for (June 10, 2025 meeting) ▼ 12.8 pts
Description as filed by funds: Election of Directors: G. Leonard Baker, Jr.
Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: G. Leonard Baker, Jr.”): 64,912,506 for, 12,381,951 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 25,344,975 for, 5,294,463 withheld, 85 abstained, 66,551 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,175,331 | 0 | 85 | 23,333 | For |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 5,208,686 | 0 | 0 | 9,874 | For |
| First Trust | 0 | 0 | 0 | 2,173,819 | Withhold |
| State Street | 4,014 | 0 | 0 | 1,560,579 | Withhold |
| Charles Schwab | 1,021,083 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 353,405 | Withhold |
| Jackson National | 198,027 | 0 | 0 | 36,347 | Mixed |
| Columbia Threadneedle | 0 | 0 | 0 | 181,631 | Withhold |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 177,736 | Withhold |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 53,708 | 0 | 0 | 74,287 | Mixed |
| Janus Detroit Street Trust | 0 | 0 | 0 | 121,285 | Withhold |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 82,385 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 75,759 | Withhold |
| AQR | 0 | 0 | 0 | 74,174 | Withhold |
| Brown Capital Management Mutual Funds | 71,812 | 0 | 0 | 0 | For |
| Putnam | 71,394 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 63,836 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 63,129 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
66% Majority: yes · of votes cast
Prior year: 81.0% for (June 10, 2025 meeting) ▼ 14.9 pts
Description as filed by funds: Election of Directors: David L. Mahoney
Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: David L. Mahoney”): 51,078,278 for, 26,216,179 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 66% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 14,743,202 for, 15,896,146 withheld, 174 abstained, 66,551 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,190,075 | 0 | 174 | 8,500 | For |
| BlackRock | 66,185 | 0 | 0 | 8,117,935 | Withhold |
| Fidelity | 2,695,332 | 0 | 0 | 2,523,228 | Mixed |
| First Trust | 0 | 0 | 0 | 2,173,819 | Withhold |
| State Street | 4,014 | 0 | 0 | 1,560,579 | Withhold |
| Charles Schwab | 1,021,083 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 353,405 | Withhold |
| Jackson National | 198,027 | 0 | 0 | 36,347 | Mixed |
| Columbia Threadneedle | 181,631 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 177,736 | Withhold |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 53,708 | 0 | 0 | 74,287 | Mixed |
| Janus Detroit Street Trust | 0 | 0 | 0 | 121,285 | Withhold |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 82,385 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 75,759 | Withhold |
| AQR | 0 | 0 | 0 | 74,174 | Withhold |
| Brown Capital Management Mutual Funds | 71,812 | 0 | 0 | 0 | For |
| Putnam | 71,394 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 63,836 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 5,140 | 0 | 0 | 57,989 | Mixed |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Prior year: 99.5% for (June 10, 2025 meeting) ▼ 0.2 pts
Description as filed by funds: Election of Directors: Joshua M. Murray
Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Joshua M. Murray”): 76,753,606 for, 540,851 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 30,619,154 for, 20,364 withheld, 4 abstained, 66,551 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,198,745 | 0 | 4 | 0 | For |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 5,218,560 | 0 | 0 | 0 | For |
| First Trust | 2,173,819 | 0 | 0 | 0 | For |
| State Street | 1,564,593 | 0 | 0 | 0 | For |
| Charles Schwab | 1,021,083 | 0 | 0 | 0 | For |
| Dimensional | 353,405 | 0 | 0 | 0 | For |
| Jackson National | 234,374 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 181,631 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 177,736 | 0 | 0 | 0 | For |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 127,995 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 121,285 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 82,385 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 75,759 | 0 | 0 | 0 | For |
| AQR | 74,174 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 71,812 | 0 | 0 | 0 | For |
| Putnam | 71,394 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 63,836 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 63,129 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Prior year: 91.2% for (June 10, 2025 meeting) ▼ 0.2 pts
Description as filed by funds: Election of Directors: Kimberly Park
Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Kimberly Park”): 70,288,833 for, 7,005,624 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 28,375,858 for, 2,269,611 withheld, 53 abstained, 66,551 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,183,863 | 0 | 53 | 14,833 | For |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 5,218,560 | 0 | 0 | 0 | For |
| First Trust | 2,173,819 | 0 | 0 | 0 | For |
| State Street | 19,626 | 0 | 0 | 1,544,967 | Withhold |
| Charles Schwab | 1,020,865 | 0 | 0 | 217 | For |
| Dimensional | 353,405 | 0 | 0 | 0 | For |
| Jackson National | 234,374 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 181,631 | Withhold |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 177,736 | Withhold |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 127,995 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 121,285 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 82,385 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 75,759 | 0 | 0 | 0 | For |
| AQR | 74,174 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 0 | 0 | 0 | 71,812 | Withhold |
| Putnam | 0 | 0 | 0 | 71,394 | Withhold |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 63,836 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 63,129 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Prior year: 98.9% for (June 10, 2025 meeting) ▼ 11.5 pts
Description as filed by funds: Election of Directors: Daniel N. Swisher, Jr.
Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Daniel N. Swisher, Jr.”): 67,594,098 for, 9,700,359 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 27,092,897 for, 3,552,559 withheld, 66 abstained, 66,551 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,190,183 | 0 | 66 | 8,500 | For |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 5,208,686 | 0 | 0 | 9,874 | For |
| First Trust | 0 | 0 | 0 | 2,173,819 | Withhold |
| State Street | 1,548,980 | 0 | 0 | 15,613 | For |
| Charles Schwab | 1,021,083 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 353,405 | Withhold |
| Jackson National | 198,027 | 0 | 0 | 36,347 | Mixed |
| Columbia Threadneedle | 181,631 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 177,736 | Withhold |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 53,708 | 0 | 0 | 74,287 | Mixed |
| Janus Detroit Street Trust | 0 | 0 | 0 | 121,285 | Withhold |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 82,385 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 75,759 | Withhold |
| AQR | 0 | 0 | 0 | 74,174 | Withhold |
| Brown Capital Management Mutual Funds | 71,812 | 0 | 0 | 0 | For |
| Putnam | 71,394 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 63,836 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 63,129 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 97.5% for (June 10, 2025 meeting) ▼ 3.4 pts
Description as filed by funds: Election of Directors: James N. Wilson
Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: James N. Wilson”): 72,730,017 for, 4,564,440 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 28,663,336 for, 1,982,153 withheld, 33 abstained, 66,551 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,183,883 | 0 | 33 | 14,833 | For |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 5,218,560 | 0 | 0 | 0 | For |
| First Trust | 2,173,819 | 0 | 0 | 0 | For |
| State Street | 19,496 | 0 | 0 | 1,545,097 | Withhold |
| Charles Schwab | 1,021,083 | 0 | 0 | 0 | For |
| Dimensional | 353,405 | 0 | 0 | 0 | For |
| Jackson National | 234,374 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 181,631 | Withhold |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 177,736 | Withhold |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 127,995 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 121,285 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 82,385 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 75,759 | 0 | 0 | 0 | For |
| AQR | 74,174 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 71,812 | 0 | 0 | 0 | For |
| Putnam | 71,394 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 63,836 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 63,129 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
69% Approved · of votes cast
Description as filed by funds: To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan.
Corcept Therapeutics Incorporated’s own tally for this item (“4. Amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan”): 53,163,364 for, 23,867,363 against — passed, per its Form 8-K filed May 28, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4 - The amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan was approved.”
Support: 69% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Corcept Therapeutics Incorporated’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 92 asset managers below reported 18,174,776 for, 12,291,035 against, 193,558 abstained, 90 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,131,618 | 4,067,130 | 1 | 0 | Mixed |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 2,540,525 | 2,678,035 | 0 | 0 | Mixed |
| First Trust | 0 | 2,173,819 | 0 | 0 | Against |
| State Street | 1,546,060 | 18,533 | 0 | 0 | For |
| Charles Schwab | 664 | 1,020,419 | 0 | 0 | Against |
| Dimensional | 0 | 353,405 | 0 | 0 | Against |
| Jackson National | 0 | 234,374 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 181,631 | 0 | 0 | Against |
| BOSTON TRUST WALDEN FUNDS | 177,736 | 0 | 0 | 0 | For |
| TIAA | 0 | 176,851 | 0 | 0 | Against |
| Royce | 0 | 0 | 132,800 | 0 | Abstain |
| Principal | 53,708 | 74,287 | 0 | 0 | Mixed |
| Janus Detroit Street Trust | 0 | 121,285 | 0 | 0 | Against |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 0 | 82,385 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 0 | 75,759 | 0 | 0 | Against |
| AQR | 0 | 74,174 | 0 | 0 | Against |
| Brown Capital Management Mutual Funds | 0 | 71,812 | 0 | 0 | Against |
| Putnam | 0 | 71,394 | 0 | 0 | Against |
| HUSSMAN INVESTMENT TRUST | 0 | 70,000 | 0 | 0 | Against |
| Invesco | 0 | 63,836 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 63,129 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement.
Corcept Therapeutics Incorporated’s own tally for this item (“3. Compensation of named executive officers”): 72,511,429 for, 4,560,385 against — passed, per its Form 8-K filed May 28, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 - The compensation of named executive officers was approved, on an advisory basis.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,157,063 | 41,683 | 1 | 0 | For |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 5,218,560 | 0 | 0 | 0 | For |
| First Trust | 2,173,819 | 0 | 0 | 0 | For |
| State Street | 1,561,483 | 3,110 | 0 | 0 | For |
| Charles Schwab | 1,021,083 | 0 | 0 | 0 | For |
| Dimensional | 353,405 | 0 | 0 | 0 | For |
| Jackson National | 36,347 | 198,027 | 0 | 0 | Mixed |
| Columbia Threadneedle | 181,631 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 0 | 177,736 | 0 | 0 | Against |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 127,995 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 121,285 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 0 | 82,385 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 75,759 | 0 | 0 | 0 | For |
| AQR | 74,174 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 71,812 | 0 | 0 | 0 | For |
| Putnam | 71,394 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 70,000 | 0 | 0 | Against |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 0 | 63,836 | 0 | 0 | Against |
Fund voting reports, all 92 managers: 29,972,397 for, 674,700 against, 58,128 abstained, 66,551 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,184,845 | 0 | 0 | 0 | For |
| State Street | 2,771,317 | 3,486 | 0 | 0 | For |
| BlackRock | 2,721,661 | 25,148 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,717,258 | 0 | 0 | 0 | For |
| Charles Schwab | 1,123,486 | 0 | 0 | 0 | For |
| Renaissance | 966,044 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 952,575 | 0 | 0 | 0 | For |
| Apollon Wealth Management, LLC | 880,534 | 0 | 0 | 0 | For |
| Vanguard | 747,292 | 0 | 0 | 0 | For |
| Northern Trust | 612,632 | 8,248 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 455,248 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 425,062 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 364,102 | 0 | 0 | Against |
| CANADA PENSION PLAN INVESTMENT BOARD | 322,401 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 268,590 | 0 | 0 | 0 | For |
| Janus Henderson | 242,570 | 0 | 0 | 0 | For |
| Goldman Sachs | 231,642 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN NATIONAL ASSOCIATION | 0 | 226,566 | 0 | 0 | Against |
| Allspring | 213,716 | 0 | 0 | 0 | For |
| Cerity Partners LLC | 204,244 | 0 | 0 | 0 | For |
| Dimensional | 199,896 | 0 | 0 | 0 | For |
| T. Rowe Price | 199,433 | 0 | 0 | 0 | For |
| Two Sigma | 191,829 | 0 | 0 | 0 | For |
| Nuveen | 190,182 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 163,726 | 0 | 0 | 0 | For |
Institutional-manager reports, all 289 managers: 23,564,880 for, 2,015,359 against, 8,075 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.4% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Corcept Therapeutics Incorporated’s own tally for this item (“2. Appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 92,656,473 for, 569,010 against — passed, per its Form 8-K filed May 28, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 - The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 30,656,732 for, 28,426 against, 20,364 abstained, 66,551 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,183,912 | 14,837 | 0 | 0 | For |
| BlackRock | 8,184,120 | 0 | 0 | 0 | For |
| Fidelity | 5,218,560 | 0 | 0 | 0 | For |
| First Trust | 2,173,819 | 0 | 0 | 0 | For |
| State Street | 1,564,463 | 130 | 0 | 0 | For |
| Charles Schwab | 1,021,083 | 0 | 0 | 0 | For |
| Dimensional | 353,405 | 0 | 0 | 0 | For |
| Jackson National | 234,374 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 181,631 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 177,736 | 0 | 0 | 0 | For |
| TIAA | 176,851 | 0 | 0 | 0 | For |
| Royce | 132,800 | 0 | 0 | 0 | For |
| Principal | 127,995 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 121,285 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 115,882 | 0 | 0 | 0 | For |
| JPMorgan | 101,479 | 0 | 0 | 0 | For |
| EA Series Trust | 97,568 | 0 | 0 | 0 | For |
| BNY Mellon | 82,385 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 75,759 | 0 | 0 | 0 | For |
| AQR | 74,174 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 71,812 | 0 | 0 | 0 | For |
| Putnam | 71,394 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 70,000 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 0 | 0 | Not Voted |
| Invesco | 63,836 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 105,966,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.68% |
| 2 | BlackRock | 7.72% |
| 3 | Fidelity | 4.92% |
| 4 | First Trust | 2.05% |
| 5 | State Street | 1.48% |
| 6 | Charles Schwab | 0.96% |
| 7 | Dimensional | 0.33% |
| 8 | Jackson National | 0.22% |
| 9 | Columbia Threadneedle | 0.17% |
| 10 | BOSTON TRUST WALDEN FUNDS | 0.17% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 3.01% |
| 2 | State Street | 2.62% |
| 3 | BlackRock | 2.59% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.56% |
| 5 | Charles Schwab | 1.06% |
| 6 | Renaissance | 0.91% |
| 7 | MPM BioImpact LLC | 0.90% |
| 8 | Apollon Wealth Management, LLC | 0.83% |
| 9 | Vanguard | 0.71% |
| 10 | Northern Trust | 0.59% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 12,151,276 | 11.47% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 9,494,822 | 8.96% | Form 13F, quarter ended March 31, 2026 |
| INGALLS & SNYDER LLC | 7,263,466 | 6.85% | Schedule 13G, filed April 21, 2026 |
| Joseph K. Belanoff, M.D. | 6,743,951 | 6.36% | Proxy statement (DEF 14A), table as of April 9, 2026 |
| G. Leonard Baker, Jr. | 5,663,946 | 5.35% | Proxy statement (DEF 14A), table as of April 9, 2026 |
| Renaissance Technologies LLC | 5,261,628 | 4.97% | Schedule 13G, filed August 13, 2026 |
| State Street | 3,200,946 | 3.02% | Form 13F, quarter ended March 31, 2026 |
| FMR (Fidelity) | 3,190,192 | 3.01% | Form 13F, quarter ended March 31, 2026 |
| James N. Wilson | 2,991,515 | 2.82% | Proxy statement (DEF 14A), table as of April 9, 2026 |
| Geode Capital | 2,713,519 | 2.56% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 105,966,000 shares outstanding, as reported by Corcept Therapeutics Incorporated on its Form 10-K dated December 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Corcept Therapeutics Incorporated's shareholder meeting held May 21, 2026, in the 2025-2026 proxy season, 357 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 4,105 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the company's named executive officers as… — Corcept Therapeutics Incorporated's filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Corcept Therapeutics Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 28, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Corcept Therapeutics Incorporated’s 10-K dated December 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Corcept Therapeutics Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Corcept Therapeutics (CORT) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/corcept-therapeutics-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.